SRDX logo

Surmodics (SRDX) Company Overview

Profile

Full Name:

Surmodics, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

March 4, 1998

Indexes:

Not included

Website:

http://www.surmodics.com

Description:

Surmodics, Inc. - a leading provider of medical devices and diagnostic technologies for healthcare system companies. The main focus is on cardiovascular diseases. The company was founded in 1979. The headquarters is located in the state of Minnesota. Surmodics, Inc. operates in two reporting business segments: the Medical Device Division - designs, develops, and manufactures interventional medical devices, primarily balloons and catheters for the treatment of peripheral artery diseases, urology, and others. The In Vitro Diagnostics Division - produces and sells components for diagnostic immunoassays, molecular tests, biomedical research.

Key Details

Price

$34.10

Market Cap

$487.49 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$126.08 M(-4.91% YoY)

Annual EPS

-$0.82(-645.45% YoY)

PE Ratio

-

Annual ROE

-9.67%

Annual Debt To Equity

0.25

Beta

0.15

Events Calendar

Earnings

Next earnings date:

May 1, 2025

Recent quarterly earnings:

Jan 30, 2025

Recent annual earnings:

Nov 8, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 7, 2000

Analyst ratings

Recent major analysts updates

Jan 30, 25 Needham
Hold
Nov 7, 24 Needham
Hold
Aug 5, 24 Needham
Hold
May 30, 24 Barrington Research
Market Perform
May 29, 24 Sidoti & Co.
Neutral
May 29, 24 Needham
Hold
May 29, 24 Lake Street
Hold
May 2, 24 Barrington Research
Outperform
May 1, 24 Needham
Buy
Apr 10, 24 Needham
Buy

Screeners with SRDX included

Growing Shares Outstanding
US stocks
Stocks below SMA 200
Stocks recommended to hold
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks
Best performing stocks last 15 years
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$34.10
SRDX price is $34.10

Price All-time High

$80.35
SRDX price is currently -57.56% below its historical high of $80.35

Price Analysts Target

$43.00
SRDX price is currently -20.70% lower than the consensus analysts' forecast

Price Most Recent Change

-0.18%
SRDX price was down -0.18% on Feb 14, 2025

Price YTD Change

-13.89%
SRDX price is down -13.89% since January 1st

Price 3-Year Change

-19.44%
SRDX price is down -19.44% over the past 3 years

Market cap

Market Cap

$487.49 M
SRDX market capitalization is $487.49 million

Market Cap 3-Year Change

-17.6%
SRDX market capitalization is down -17.6% over the past 3 years

Market Cap All-time High

$1.07 B
SRDX market capitalization is currently -54.56% below its historical high of $1.07 billion

Market Cap Sector Rank

66.37%
SRDX market capitalization is higher than 66.37% of companies in Healthcare sector

Technical

Beta

0.15
SRDX beta is 0.15

200-day SMA

$38.76
SRDX price is currently -12.02% below its 200-day simple moving average

14-day RSI

34.82
SRDX 14-day relative strength index is 34.82

30-day Relative Volume

0.86
SRDX 30-day relative volume is 0.86

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$126.08 M
SRDX annual revenue is $126.08 million

Annual Revenue Analysts Estimate

$131.59 M
SRDX annual revenue is currently -4.19% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-4.91%
SRDX annual revenue is down -4.91% year-on-year

Annual Revenue Sector Rank

59.71%
SRDX annual revenue is higher than 59.71% of companies in Healthcare sector

Profit

Annual Gross Profit

$54.69 M
SRDX annual gross profit is $54.69 million

Annual Gross Margin

43.38%
SRDX annual gross profit margin is 43.38%

Annual Operating Profit

-$5.64 M
SRDX annual operating income is -$5.64 million

Annual Operating Margin

-4.48%
SRDX annual operating profit margin is -4.48%

Annual Net Income

-$11.54 M
SRDX annual net profit is -$11.54 million

Annual Net Margin

-9.15%
SRDX annual net profit margin is -9.15%

EPS

Annual EPS

-$0.82
SRDX annual earnings per share is -$0.82

Annual EPS Analysts Estimate

-$0.18
SRDX annual earnings per share is currently +364.06% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-645.45%
SRDX annual earnings per share is down -645.45% year-on-year

Annual EPS Sector Rank

64.37%
SRDX annual earnings per share is higher than 64.37% of companies in Healthcare sector

ROA & ROE

Annual ROA

-6.34%
SRDX annual return on assets is -6.34%

Annual ROE

-9.67%
SRDX annual return on equity is -9.67%

EBIT & EBITDA

Annual EBIT

-$5.64 M
SRDX annual earnings before interest & taxes is -$5.64 million

Annual EBITDA

$3.05 M
SRDX annual EBITDA is $3.05 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
SRDX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
SRDX price to earnings ratio is unknown

PB Ratio

PB Ratio

4.36
SRDX price to book ratio is 4.36

PB Ratio Sector Rank

77.14%
SRDX price to book ratio is higher than 77.14% of companies in Healthcare sector

PS Ratio

PS Ratio

3.89
SRDX price to sales ratio is 3.89

PS Ratio Sector Rank

54.25%
SRDX price to sales ratio is higher than 54.25% of companies in Healthcare sector

Enterprise value

Enterprise Value

$490.38 M
SRDX enterprise value is $490.38 million

Enterprise Value Sector Rank

67.25%
SRDX enterprise value is higher than 67.25% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

218.53
SRDX EV/EBITDA is 218.53

EV/EBITDA Sector Rank

98.78%
SRDX EV/EBITDA is higher than 98.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.96
SRDX annual current ratio is 3.96

Annual Quick Ratio

3.22
SRDX annual quick ratio is 3.22

Leverage

Annual Debt To Equity

0.25
SRDX annual debt to equity ratio is 0.25

Annual Interest Coverage Ratio

-1.59
SRDX annual interest coverage ratio is -1.59

Risk & Stability

Piotroski F-Score

5
SRDX piotroski f-score is 5

Altman Z-Score

6.51
SRDX altman z-score is 6.51

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$178.56 M
SRDX annual total assets is $178.56 million

Annual Non Current Assets

$97.26 M
SRDX annual long term assets is $97.26 million

Annual Current Assets

$81.30 M
SRDX annual total current assets is $81.30 million

Annual Cash & Cash Equivalents

$36.12 M
SRDX annual cash & cash equivalents is $36.12 million

Equity

Annual Book Value

$118.90 M
SRDX annual book value is $118.90 million

Annual Working Capital

$60.76 M
SRDX annual working capital is $60.76 million

Liabilities

Annual Total Liabilities

$59.66 M
SRDX annual total liabilities is $59.66 million

Annual Total Long Term Liabilities

$39.12 M
SRDX annual total long term liabilities is $39.12 million

Annual Current Liabilities

$20.54 M
SRDX annual total current liabilities is $20.54 million

Annual Accounts Payable

$2.79 M
SRDX annual accounts payable is $2.79 million

Debt

Annual Total Debt

$33.24 M
SRDX annual total debt is $33.24 million

Annual Total Debt 1-Year Change

-0.03%
SRDX annual total debt is down -0.03% year-on-year

Annual Long Term Debt

$32.20 M
SRDX annual long term debt is $32.20 million

Annual Short Term Debt

$1.04 M
SRDX annual short term debt is $1.04 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$131.72 M
SRDX annual total expenses is $131.72 million

Annual Operating Expenses

$60.34 M
SRDX annual total operating expenses is $60.34 million

Annual Cost Of Goods Sold

$71.39 M
SRDX annual cost of goods sold is $71.39 million

Annual SGA

$56.84 M
SRDX annual SGA is $56.84 million

Annual D&A

$8.69 M
SRDX annual depreciation & amortization is $8.69 million

Annual Interest Expense

$3.54 M
SRDX annual interest expense is $3.54 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$248.00 K
SRDX annual cash flow from operations is $248.00 thousand

Annual CFO 1-Year Change

-97.64%
SRDX annual cash flow from operations is down -97.64% year-on-year

Annual CFI

-$2.94 M
SRDX annual cash flow from investing activities is -$2.94 million

Annual CFI 1-Year Change

+56.95%
SRDX annual cash flow from investing activities is up +56.95% year-on-year

Annual CFF

-$2.95 M
SRDX annual cash flow from financing activities is -$2.95 million

Annual CFF 1-Year Change

-116.03%
SRDX annual cash flow from financing activities is down -116.03% year-on-year

Free CashFlow

Annual FCF

-$3.24 M
SRDX annual free cash flow is -$3.24 million

Annual FCF 1-Year Change

-142.71%
SRDX annual free cash flow is down -142.71% year-on-year

CAPEX

Annual CAPEX

$3.49 M
SRDX annual capital expenditures is $3.49 million

Annual CAPEX 1-Year Change

+19.67%
SRDX annual capital expenditures is up +19.67% year-on-year

Institutional Ownership

Similar stocks

ORGO logo
Organogenesis Holdings (ORGO)
INNV logo
InnovAge Holding (INNV)
SNDA logo
Sonida Senior Living (SNDA)
KALV logo
KalVista Pharmaceuticals (KALV)
Septerna (SEPN)
SVRA logo
Savara (SVRA)
CELC logo
Celcuity (CELC)
ARCT logo
Arcturus Therapeutics Holdings (ARCT)
CMPX logo
Compass Therapeutics (CMPX)

FAQ

  • What is the ticker symbol for Surmodics?
  • Does Surmodics pay dividends?
  • What sector is Surmodics in?
  • What industry is Surmodics in?
  • What country is Surmodics based in?
  • When did Surmodics go public?
  • Is Surmodics in the S&P 500?
  • Is Surmodics in the NASDAQ 100?
  • Is Surmodics in the Dow Jones?
  • When was Surmodics's last earnings report?
  • When does Surmodics report earnings?
  • Should I buy Surmodics stock now?

What is the ticker symbol for Surmodics?

The ticker symbol for Surmodics is NASDAQ:SRDX

Does Surmodics pay dividends?

No, Surmodics does not pay dividends

What sector is Surmodics in?

Surmodics is in the Healthcare sector

What industry is Surmodics in?

Surmodics is in the Medical Devices industry

What country is Surmodics based in?

Surmodics is headquartered in United States

When did Surmodics go public?

Surmodics's initial public offering (IPO) was on March 4, 1998

Is Surmodics in the S&P 500?

No, Surmodics is not included in the S&P 500 index

Is Surmodics in the NASDAQ 100?

No, Surmodics is not included in the NASDAQ 100 index

Is Surmodics in the Dow Jones?

No, Surmodics is not included in the Dow Jones index

When was Surmodics's last earnings report?

Surmodics's most recent earnings report was on Jan 30, 2025

When does Surmodics report earnings?

The next expected earnings date for Surmodics is May 1, 2025

Should I buy Surmodics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions